ONCY Oncolytics Biotech Inc
Company Analysis
Latest News
🟢 Oncolytics Biotech is trading 5% up today after announcement of pelareorep method-of-use patents
Oncolytics Biotech is trading at $0.50, up +5.32%, following its announcement of new pelareorep method-of-use patents; coverage has not confirmed the...
Oncolytics Secures New Patents for Pelareorep, Extending Protection into the Late 2040s
Oncolytics Biotech Inc. announced a strategic update on its intellectual property portfolio for its lead immunotherapy candidate, pelareorep. The company has...
🟢 Oncolytics Biotech is trading 5.64% up in pre-market — patent update is a possible catalyst
Oncolytics Biotech is trading at $0.50, up 5.64% in pre-market, with its patent announcement a plausible but unconfirmed overnight catalyst. - On October 12,...
🟢 Oncolytics Biotech is trading 5.66% up in after-hours trading — cause unconfirmed
Oncolytics Biotech is trading at $0.50, up 5.66%, in after-hours trading; the cause of the rise remains unconfirmed. - No confirmed company-specific...
🔴 Oncolytics Biotech is trading 10.2% down — catalyst remains unconfirmed
Oncolytics Biotech is trading 10.22% down at $0.50, with the cause of the October 12, 2026 decline unconfirmed. - The company reported accelerating enrollment...
🔴 Oncolytics Biotech is trading 6% down — cause remains unconfirmed
Oncolytics Biotech is trading at $0.53, down -5.55%, with the decline unexplained. - No reliable report ties the October 12 decline to a specific company...
🟢 Oncolytics Biotech is trading 5% up in pre-market with no confirmed catalyst
Oncolytics Biotech is trading 5.31% higher at $0.59 in pre-market on October 12, versus its October 9 close of $0.56. No reliable source directly attributes...
🔴 Oncolytics Biotech is trading 5% down amid biotech-sector weakness
Oncolytics Biotech is trading at $0.57, down 5.14%, amid biotech-sector weakness; no clear catalyst for the decline was identified. - An October 8 search...
🟢 Oncolytics Biotech is trading 5.6% up in pre-market
Oncolytics Biotech is trading 5.55% up at $0.63 in the supplied pre-market price context, with no clear company-specific catalyst identified. - The stock...
🟢 Oncolytics Biotech is trading 5.6% up in after-hours trading with no confirmed catalyst
Oncolytics Biotech is trading at $0.63, up 5.55% in after-hours trading; the catalyst remains unclear. - It closed the regular session at $0.60 on October 5,...
🔴 Oncolytics Biotech is trading 5% down — no confirmed catalyst
Oncolytics Biotech is trading 5.39% down at $0.60 on October 5, 2026; no confirmed catalyst has emerged. - No clear company-specific announcement explaining...
🔴 Oncolytics Biotech is trading 5% down; no clear catalyst identified
Oncolytics Biotech is trading 5.28% lower at $0.63; no clear company-specific catalyst for the October 1 decline has been identified. - The latest company...
Oncolytics Reports Accelerating Enrollment in Colorectal Cancer Trial, Interim Data Expected by Year-End
Oncolytics Biotech Inc. announced accelerating patient enrollment for its randomized REO 033 study evaluating its lead drug, pelareorep, in second-line...
🟢 Oncolytics Biotech is trading 5% up with no identified catalyst
Oncolytics Biotech is trading at $0.72, up 5.08% on September 28, 2026; no clearly documented catalyst for the intraday gain surfaced in available search...
🟢 Oncolytics Biotech is trading 5.81% up in pre-market amid broader biotech strength
Oncolytics Biotech is trading at $0.72, up 5.81% now in pre-market, aligned with broader biotechnology strength; no new company-specific catalyst was...
🔴 Oncolytics Biotech is trading 5% down today with no confirmed company-specific catalyst
Oncolytics Biotech is trading 5% lower at $0.68, with the decline appearing to reflect stock-specific selling; no confirmed company-specific catalyst has been...
🔴 Oncolytics Biotech is trading 5.9% down today amid unexplained selling
Oncolytics Biotech is trading 5.9% down at $0.72, reflecting unexplained selling; no clear company-specific catalyst was identified for September 22, 2026. -...
🟢 Oncolytics Biotech is trading 6.92% up today after rebounding from September 11’s $0.75 close
Oncolytics Biotech is trading 6.92% up at $0.80 after rebounding from the $0.75 close on September 11, 2026. - No clear company-specific catalyst has been...
🟢 Oncolytics Biotech is trading 6.75% up today — no clear company-specific catalyst identified
Oncolytics Biotech is trading 6.75% up at $0.80, with no clear company-specific catalyst identified for the September 14 move. - The move reverses its recent...
🟢 Oncolytics Biotech is trading 5.94% up today with no clear company-specific catalyst identified
Oncolytics Biotech is trading 5.94% up at $0.79, with no clear company-specific catalyst identified for September 14, 2026. - The latest announcement, dated...